BTCY logo

Biotricity, Inc. (BTCY)

Profile

Full Name

Biotricity, Inc.

Ticker

NASDAQ: BTCY

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 16, 2018

Indexes

Not included

Website

http://www.biotricity.com

Employees

55

Key Details

Price

$0.39(-5.87%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$12.06M(+25.15% YoY)

Annual EPS

-$1.66(+26.42% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.39
    BTCY price is $0.39

    30-Day Relative Volume

    1.09
    BTCY 30-day relative volume is 1.09

    Price Performance

    Price Most recent change

    -5.87%
    BTCY price was down -5.87% on Jul 11, 2025

    Price YTD change

    +32.85%
    BTCY price is up +32.85% since January 1st

    Price 1-year change

    -57.21%
    BTCY price is down -57.21% year-on-year

    Price 3-year change

    -95.69%
    BTCY price is down -95.69% over the past 3 years

    Price Range

    Price All-time high

    $117.00
    BTCY price is currently -99.67% below its historical high of $117.00

    Price 3-year low

    $0.19
    BTCY price is currently +106.99% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.59M
    BTCY market capitalization is $9.59 million

    Market cap 3-year change

    -87.55%
    BTCY market capitalization is down -87.55% over the past 3 years

    Market cap All-time high

    $309.83M
    BTCY market capitalization is currently -96.90% below its historical high of $309.83 million

    Market cap sector rank

    16.36%
    BTCY market capitalization is higher than 16.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +15.09%
    BTCY shares outstanding is up +15.09% year-on-year

    Shares Outstanding 3-Year Change

    +189.2%
    BTCY shares outstanding is up +189.2% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -0.61
    BTCY beta is -0.61

    200-day SMA

    $0.40
    BTCY price is currently -4.70% below its 200-day simple moving average

    50-day SMA

    $0.47
    BTCY price is currently -17.91% below its 50-day simple moving average

    RSI

    43.82
    BTCY 14-day relative strength index is 43.82

    Volume

    1.09
    BTCY 30-day relative volume is 1.09

    ATR

    $0.06
    BTCY average true range is $0.06

    10-day Historical Volatility

    124.37%
    BTCY 10-day historical volatility is 124.37%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $12.06M
    BTCY annual revenue is $12.06 million

    Revenue Analysts estimate

    $13.70M
    BTCY annual revenue is currently -11.95% lower than the consensus analysts' forecast

    Revenue 1-year change

    +25.15%
    BTCY annual revenue is up +25.15% year-on-year

    Revenue Sector rank

    30.36%
    BTCY annual revenue is higher than 30.36% of companies in Healthcare sector

    EPS

    EPS

    -$1.66
    BTCY annual earnings per share is -$1.66

    EPS Analysts estimate

    -$0.58
    BTCY annual earnings per share is currently +186.21% higher than the consensus analysts' forecast

    EPS 1-year change

    +26.42%
    BTCY annual earnings per share is up +26.42% year-on-year

    EPS Sector rank

    42.76%
    BTCY annual earnings per share is higher than 42.76% of companies in Healthcare sector

    Profit

    Gross profit

    $8.36M
    BTCY annual gross profit is $8.36 million

    Gross margin

    69.27%
    BTCY annual gross profit margin is 69.27%

    Operating profit

    -$8.83M
    BTCY annual operating income is -$8.83 million

    Operating margin

    -73.18%
    BTCY annual operating profit margin is -73.18%

    Net income

    -$14.09M
    BTCY annual net profit is -$14.09 million

    Net margin

    -116.84%
    BTCY annual net profit margin is -116.84%

    Expenses

    Total expenses

    $20.89M
    BTCY annual total expenses is $20.89 million

    Operating expenses

    $17.18M
    BTCY annual total operating expenses is $17.18 million

    Cost of goods sold

    $3.71M
    BTCY annual cost of goods sold is $3.71 million

    Selling, general & administrative expenses

    $14.61M
    BTCY annual SGA is $14.61 million

    Depreciation and amortization

    $6000.00
    BTCY annual depreciation & amortization is $6000.00

    Interest expense

    $5.19M
    BTCY annual interest expense is $5.19 million

    Income tax

    $0.00
    BTCY annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$8.90M
    BTCY annual earnings before interest & taxes is -$8.90 million

    EBITDA

    -$8.90M
    BTCY annual EBITDA is -$8.90 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.94M
    BTCY annual total assets is $5.94 million

    Non current assets

    $1.47M
    BTCY annual long term assets is $1.47 million

    Current assets

    $4.47M
    BTCY annual total current assets is $4.47 million

    Cash and cash equivalents

    $786.10K
    BTCY annual cash & cash equivalents is $786.10 thousand

    Accounts receivable

    $1.47M
    BTCY annual accounts receivable is $1.47 million

    Inventory

    $1.88M
    BTCY annual inventory is $1.88 million

    Liabilities

    Total liabilities

    $35.92M
    BTCY annual total liabilities is $35.92 million

    Long term liabilities

    $13.22M
    BTCY annual total long term liabilities is $13.22 million

    Current liabilities

    $22.70M
    BTCY annual total current liabilities is $22.70 million

    Accounts payable

    $5.22M
    BTCY annual accounts payable is $5.22 million

    Debt

    Total debt

    $23.88M
    BTCY annual total debt is $23.88 million

    Total debt 1-year change

    +22.17%
    BTCY annual total debt is up +22.17% year-on-year

    Long term debt

    $11.78M
    BTCY annual long term debt is $11.78 million

    Short term debt

    $12.09M
    BTCY annual short term debt is $12.09 million

    Equity & Capital

    Shareholders equity

    -$29.98M
    BTCY annual stockholders equity is -$29.98 million

    Book value

    -$31.47M
    BTCY annual book value is -$31.47 million

    Retained earnings

    -$127.50M
    BTCY annual retained earnings is -$127.50 million

    Working capital

    -$18.23M
    BTCY annual working capital is -$18.23 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$6.69M
    BTCY annual cash flow from operations is -$6.69 million

    Cash from operations 1-year change

    +50.59%
    BTCY annual cash flow from operations is up +50.59% year-on-year

    Cash from investing

    -
    BTCY annual cash flow from investing activities value is unknown

    Cash from investing 1-year change

    -
    BTCY annual cash flow from investing activities 1-year change is unknown

    Cash from financing

    $6.74M
    BTCY annual cash flow from financing activities is $6.74 million

    Cash from financing 1-year change

    +236.82%
    BTCY annual cash flow from financing activities is up +236.82% year-on-year

    CAPEX

    CAPEX

    -
    BTCY annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    BTCY annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$6.69M
    BTCY annual free cash flow is -$6.69 million

    Free cash flow 1-year change

    +50.59%
    BTCY annual free cash flow is up +50.59% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    69.27%
    BTCY annual gross profit margin is 69.27%

    Operating margin

    -73.18%
    BTCY annual operating profit margin is -73.18%

    Net margin

    -116.84%
    BTCY annual net profit margin is -116.84%

    ROA & ROE

    ROA

    -226.36%
    BTCY annual return on assets is -226.36%

    ROE

    47.02%
    BTCY annual return on equity is 47.02%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BTCY price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BTCY price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.30
    BTCY price to book ratio is -0.30

    PB ratio Sector rank

    11.99%
    BTCY price to book ratio is higher than 11.99% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.72
    BTCY price to sales ratio is 0.72

    PS ratio Sector rank

    18.77%
    BTCY price to sales ratio is higher than 18.77% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $34.54M
    BTCY enterprise value is $34.54 million

    Enterprise value Sector rank

    32.92%
    BTCY enterprise value is higher than 32.92% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -6.77
    BTCY EV/EBITDA is -6.77

    EV/EBITDA Sector rank

    19.26%
    BTCY EV/EBITDA is higher than 19.26% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.20
    BTCY annual current ratio is 0.20

    Quick ratio

    0.11
    BTCY annual quick ratio is 0.11

    Leverage

    Debt to equity

    -0.75
    BTCY annual debt to equity ratio is -0.75

    Interest coverage ratio

    -1.71
    BTCY annual interest coverage ratio is -1.71

    Risk & Stability

    Piotroski F-Score

    4
    BTCY piotroski f-score is 4

    Altman Z-Score

    -36.47
    BTCY altman z-score is -36.47

    Analyst ratings

    Recent major analysts updates

    Nov 18, 24 HC Wainwright & Co.
    Neutral
    Nov 20, 23 HC Wainwright & Co.
    Neutral
    Jul 5, 23 HC Wainwright & Co.
    Buy
    Feb 15, 23 HC Wainwright & Co.
    Buy
    Jul 15, 22 Maxim Group
    Hold
    Jul 15, 22 HC Wainwright & Co.
    Buy
    Mar 7, 22 Lake Street
    Buy
    Nov 23, 21 HC Wainwright & Co.
    Buy
    Jul 1, 21 Northland Capital Markets
    Outperform

    Institutional Ownership

    Screeners with BTCY included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks recommended to hold
    Earnings today
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Earnings this week
    • What is the ticker symbol for Biotricity, Inc.?
    • Does Biotricity, Inc. pay dividends?
    • What sector is Biotricity, Inc. in?
    • What industry is Biotricity, Inc. in?
    • What country is Biotricity, Inc. based in?
    • When did Biotricity, Inc. go public?
    • Is Biotricity, Inc. in the S&P 500?
    • Is Biotricity, Inc. in the NASDAQ 100?
    • Is Biotricity, Inc. in the Dow Jones?
    • When was Biotricity, Inc.'s last earnings report?
    • When does Biotricity, Inc. report earnings?

    What is the ticker symbol for Biotricity, Inc.?

    The ticker symbol for Biotricity, Inc. is NASDAQ:BTCY

    Does Biotricity, Inc. pay dividends?

    No, Biotricity, Inc. does not pay dividends

    What sector is Biotricity, Inc. in?

    Biotricity, Inc. is in the Healthcare sector

    What industry is Biotricity, Inc. in?

    Biotricity, Inc. is in the Medical Devices industry

    What country is Biotricity, Inc. based in?

    Biotricity, Inc. is headquartered in United States

    When did Biotricity, Inc. go public?

    Biotricity, Inc.'s initial public offering (IPO) was on February 16, 2018

    Is Biotricity, Inc. in the S&P 500?

    No, Biotricity, Inc. is not included in the S&P 500 index

    Is Biotricity, Inc. in the NASDAQ 100?

    No, Biotricity, Inc. is not included in the NASDAQ 100 index

    Is Biotricity, Inc. in the Dow Jones?

    No, Biotricity, Inc. is not included in the Dow Jones index

    When was Biotricity, Inc.'s last earnings report?

    Biotricity, Inc.'s most recent earnings report was on July 11, 2025

    When does Biotricity, Inc. report earnings?

    The date for Biotricity, Inc.'s next earnings report has not been announced yet
    On this page